{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:42:09Z","timestamp":1777668129195,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:00:00Z","timestamp":1474329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10238-016-0437-y","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T05:55:43Z","timestamp":1474350943000},"page":"411-414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc)"],"prefix":"10.1007","volume":"17","author":[{"given":"Gabriele","family":"Valentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Vettori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Irace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Iudici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Tolone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovico","family":"Docimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialuisa","family":"Bocchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Sanduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"437_CR1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.2010.136929","volume":"70","author":"J Avouac","year":"2011","unstructured":"Avouac J, Fransen J, Walker UA, et al. EUSTAR Group. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011;70:476\u201381.","journal-title":"Ann Rheum Dis"},{"key":"437_CR2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/annrheumdis-2012-202295","volume":"72","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Bellando-Randone S, Lepri G, Bruni C, Guiducci S. Very early versus early disease: the evolving definition of the \u2018many faces\u2019 of systemic sclerosis. Ann Rheum Dis. 2013;72:319\u201321.","journal-title":"Ann Rheum Dis"},{"key":"437_CR3","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008;58:3902\u201312.","journal-title":"Arthritis Rheum"},{"key":"437_CR4","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/acr.22304","volume":"66","author":"G Valentini","year":"2014","unstructured":"Valentini G, Marcoccia A, Cuomo G, et al. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibodies or capillaroscopic positivity or both. Arthritis Care Res. 2014;66:1520\u20137.","journal-title":"Arthritis Care Res"},{"key":"437_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03009742.2012.736532","volume":"42","author":"DM Wuttge","year":"2013","unstructured":"Wuttge DM, Lood C, Tufvesson E, et al. Increased serum type I interferon activity in early systemic sclerosis is associated with antibodies against Sj\u00f6gren\u2019s syndrome antigens and nuclear ribonucleoprotein antigens. Scand J Rheumatol. 2013;42:235\u201340.","journal-title":"Scand J Rheumatol"},{"key":"437_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/03009742.2014.926566","volume":"44","author":"CZ Camargo","year":"2015","unstructured":"Camargo CZ, Sekiyama JY, Arismendi MI, Kayser C. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease. Scand J Rheumatol. 2015;44:48\u201355.","journal-title":"Scand J Rheumatol"},{"key":"437_CR7","unstructured":"Frech TM, Murtaugh M, Gordon JK et al. Longitudinal assessment of gastrointestinal symptoms in the prospective registry of early systemic sclerosis cohort [abstract]. Arthritis Rheumatol. 2015; 67 suppl 10."},{"key":"437_CR8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2014.11.002","volume":"14","author":"G Valentini","year":"2015","unstructured":"Valentini G. Undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (so far referred to as very early\/early SSc or pre-SSc). Autoimmun Rev. 2015;14:210\u20133.","journal-title":"Autoimmun Rev"},{"key":"437_CR9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L Bon van","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014;370:433\u201343.","journal-title":"N Engl J Med"},{"key":"437_CR10","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen Van den","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J, et al. Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"437_CR11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G","volume":"43","author":"H Poormoghin","year":"2000","unstructured":"Poormoghin H, Lucas M, Fertig N, Medsger TA Jr. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum. 2000;43:444\u201351.","journal-title":"Arthritis Rheum"},{"key":"437_CR12","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4236","volume":"15","author":"G Valentini","year":"2013","unstructured":"Valentini G, Marcoccia A, Cuomo G, et al. Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers. Arthritis Res Ther. 2013;15:R63.","journal-title":"Arthritis Res Ther"},{"key":"437_CR13","doi-asserted-by":"crossref","first-page":"e2657","DOI":"10.1371\/journal.pone.0002657","volume":"3","author":"S Aidoudi","year":"2008","unstructured":"Aidoudi S, Bujakowska K, Kieffer N. Bikfalvi A The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis. PLoS ONE. 2008;3:e2657.","journal-title":"PLoS ONE"},{"key":"437_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10585-010-9311-6","volume":"27","author":"T Wiesner","year":"2010","unstructured":"Wiesner T, Bugl S, Mayer F, Hartmann JT, Kopp H-G. Differential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancer. Clin Exp Metastasis. 2010;27:141\u20139.","journal-title":"Clin Exp Metastasis"},{"key":"437_CR15","first-page":"iii26","volume":"45","author":"JHW Distler","year":"2006","unstructured":"Distler JHW, Gay S, Distler O. Angiogenesis and vasculogenesis in systemic sclerosis. Rheumatology. 2006;45:iii26\u20137.","journal-title":"Rheumatology"},{"key":"437_CR16","unstructured":"Volkmann ER, Tashkin DP, Roth M and Scleroderma Lung Study II Group. CXCL4 does not predict extent or progression of interstitial lung disease in systemic sclerosis [abstract]. Arthritis Rheumatol. 2015; 67 suppl 10."}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-016-0437-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-016-0437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-016-0437-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T01:56:14Z","timestamp":1501552574000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-016-0437-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1007\/s10238-016-0437-y","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}